Baxiva AG
PrivateLast Round
Accelerator
Feb 23, 2026
Total Funding Raised
$3.19M
Company Overview
Baxiva AG is a biotechnology company that develops next-generation glycoconjugate vaccines to prevent serious infections caused by Gram-negative bacteria.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Baxiva AG Comparables
Compare Baxiva AG with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Omniose | 83% | |
| Glycovax Pharma | 81% | |
| Matrivax Research & Development Corporation | 78% |
Baxiva AG Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Accelerator | Feb 23, 2026 | ||||
| Grant | Aug 22, 2025 |
Key People
Founding team and executive leadership
Baxiva AG Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| CARB-X | Grant |
| Venture Kick | Accelerator |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 3, 2026
Monthly visitors increased 69% MoM, reaching 1.4K.
- Mar 3, 2026
Monthly visitors grew 2090% MoM, from 39 to 854.
Recent news
Latest coverage and updates
- attends_eventJun 23, 2026
Baxiva US$3M attended event 2026 Venture Awards on Jun 15th '26.
- recognized_asJun 16, 2026
Baxiva US$3M recognized as first place in their respective categories at Venture awards on Jun 15th '26.
Baxiva AG Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Baxiva AG's valuation, stock price, and market status.
Is Baxiva AG a public or private company?
Baxiva AG is a private company.
What is the current stock price of Baxiva AG?
Baxiva AG is a private company with no public stock price. No recent secondary market data is available.
How much is Baxiva AG worth (valuation)?
Valuation information for Baxiva AG is not publicly available.
Can I buy Baxiva AG stock?
Baxiva AG shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Baxiva AG's last funding round?
Baxiva AG's most recent funding round was Accelerator on February 23, 2026.
Who are the main investors in Baxiva AG?
Key investors in Baxiva AG include CARB-X, Venture Kick.
Will Baxiva AG IPO soon?
No public IPO plans have been announced for Baxiva AG.
How can I track Baxiva AG secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Baxiva AG's secondary market activity and sign up for updates.